However, when analyzing the association between Gal-3 and mRS, the Liu (2020) results may lead to the possible source of heterogeneity because this study identified the combined effect of NT-proBNP and galectin-3 on ischemic stroke patients' clinical outcomes rather than Gal-3 alone. Here, NPPB is linked to ischemic stroke.